Clinical Research Meets Clinical Practice through Real World Evidence

Late phase research is undergoing a rapid transformation due to the impact of healthcare digitization and the greater availability of and access to real world data (RWD).

Register today to be alerted when our newest RWE white paper is published. You’ll get insights on how to prepare for and leverage the expanded use of RWD and technology to transform and optimise your late phase research.

  • Be prepared to respond to the anticipated real world evidence (RWE) demands coming from the 21st Century Cures Act.
  • Learn how the use of RWE is expanding beyond supporting regulatory decisions. Life science companies are increasingly turning to RWE to demonstrate strong product value propositions and drive successful reimbursement decisions globally.
  • Understand how technology advancements are making RWD more readily available for late phase research and enabling deep analytics to underpin more informed decisions for clinical research efficiency and other applications.